Cefixime EP Impurity D

Product Description
CAT No.
ALN-C081005
CAS No.
97164-56-2
Mol. F.
C16H15N5O7S2
Mol. Wt.
453.4
Stock
Please Inquire
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : (6R,7R)-7-[[(E)-2-(2-Aminothiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (as per EP)
Smiles : O=C(C(N12)=C(C=C)CS[C@]2([H])[C@H](NC(/C(C3=CSC(N)=N3)=N/OCC(O)=O)=O)C1=O)O
Inchi : InChI=1S/C16H15N5O7S2/c1-2-6-4-29-14-10(13(25)21(14)11(6)15(26)27)19-12(24)9(20-28-3-8(22)23)7-5-30-16(17)18-7/h2,5,10,14H,1,3-4H2,(H2,17,18)(H,19,24)(H,22,23)(H,26,27)/b20-9-/t10-,14+/m0/s1
Synonym : cefixime (E)-isomer
Technical Data
Reference
Analytical method development and validation of cefixime and azithromycin by using RP-HPLC
By Sireesha, E.; Reddy, L. Ramachandra; Dhachinamoorthi, D.nFrom World Journal of Pharmacy and Pharmaceutical Sciences (2019), 8(9), 1160-1177
Stability indicating hplc method for the quantification of cefixime, ornidazole and moxifloxacin in solid dosage forms
By Palacharla, Suresh Kumar; Mohan, G. V. Krishna – From Rasayan Journal of Chemistry (2018), 11(4), 1696-1714
Validated stability-indicating HPTLC method for cefixime and azithromycin with preparative isolation, identification, and characterization of degradation products
By Gawande, V. T.; Bothara, K. G.; Satija, C. O. – From Acta Chromatographica (2018), 30(4), 212-218
RFQ